QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) All Versions of this Article: 10/1/2    most recent 15228517-2007-041v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Hägerstrand, D. Articles by Östman, A. PubMed PubMed Citation

Gene expression analyses of grade II gliomas and identification of rPTPβ/ as a candidate oligodendroglioma marker

Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden (D.H., A.E., M.N., A.Ö.); Department of Neuroscience, Uppsala University, Uppsala University Hospital, Uppsala, Sweden (A.S.); Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden (S.S.); Department of Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden (T.O., M.H., H.K.); Department of Pathology, Helsinki University and University Hospital, Helsinki, Finland (H.K.)

Address correspondence to Arne Östman, Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, S-171 76 Stockholm, Sweden (arne.ostman{at}ki.se).

Grade II gliomas are morphologically and clinically heterogeneous tumors for which histopathological typing remains the major tool for clinical classification. To what extent the major histological subtypes—astrocytomas, oligodendrogliomas, and oligoastrocytomas—constitute true biological entities is largely unresolved. Furthermore, morphological classification is often ambiguous and would be facilitated by specific subtype markers. In this study, 23 grade II gliomas were expression-profiled and subjected to hierarchical clustering. All six oligodendrogliomas were grouped together in one of two major clusters; a significant correlation was thus observed between gene expression and histopathological subtype. Supervised analyses were performed to identify genes differentiating oligodendrogliomas from other grade II tumors. In a leave-one-out test using 10 features for classification, 20 out of 23 tumors were correctly classified. Among the most differentially expressed genes was rPTPβ/. The expression of the rPTP β/ protein in oligodendrogliomas and astrocytomas was further validated by immunohistochemistry in an independent set of tumors. All 11 oligodendrogliomas of this set displayed strong staining. In contrast, neoplastic astrocytes were mostly negative for rPTPβ/ staining. In summary, this study demonstrates a correlation between gene expression pattern and histological subtype in grade II gliomas. Furthermore, the results from the immunohistochemical analyses of rPTPβ/ expression should prompt further evaluation of this protein as a novel oligodendroglioma marker.

Key Words: Grade II glioma • histological marker • microarray • oligodendroglioma • rPTPβ/